KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) Return on Equity (2016 - 2025)

Boston Scientific's Return on Equity history spans 17 years, with the latest figure at 8.66% for Q2 2025.

  • For Q2 2025, Return on Equity fell 1060.0% year-over-year to 8.66%; the TTM value through Jun 2025 reached 8.66%, down 1060.0%, while the annual FY2025 figure was 0.13%, 4.0% up from the prior year.
  • Return on Equity for Q2 2025 was 8.66% at Boston Scientific, down from 0.19% in the prior quarter.
  • Across five years, Return on Equity topped out at 1.94% in Q2 2024 and bottomed at 165.82% in Q2 2023.
  • The 5-year median for Return on Equity is 0.09% (2023), against an average of 12.25%.
  • The largest annual shift saw Return on Equity skyrocketed 16776bps in 2024 before it crashed -1060bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.15% in 2021, then tumbled by -75bps to 0.04% in 2022, then surged by 123bps to 0.08% in 2023, then soared by 2255bps to 1.94% in 2024, then tumbled by -546bps to 8.66% in 2025.
  • Per Business Quant, the three most recent readings for BSX's Return on Equity are 8.66% (Q2 2025), 0.19% (Q1 2025), and 1.94% (Q2 2024).